Minerva Neurosciences
NERV • NASDAQ • Stock Fundamentals
Minerva Neurosciences is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Remy Luthringer, with a market cap of $215.2M.
Market Cap$215.2M
Employees9.0
CEORemy Luthringer
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 5, 2026 · 1 month 9 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Minerva Neurosciences FAQ
Common questions about Minerva Neurosciences
Minerva Neurosciences (NERV) has a market capitalization of $215.2M and trades on NASDAQ.
Minerva Neurosciences has approximately 9 employees.